Glipizide Tablet
Product Images NDC 72888-231

This is a description for glipiZIDE tablets. Each tablet contains 10 mg of glipiZIDE. The dosage and use information can be found in the accompanying prescribing information. The tablets should be stored at a temperature of 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The tablets are distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. The tablets should be dispensed in a tightly closed container with a child-resistant closure. It is important to keep this medication out of the reach of children.*

Each tablet contains glipizide, USP 10 mg. It is recommended to see the accompanying prescribing information for dosage and use. The tablets should be stored at a temperature of 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F). They should be dispensed in a tightly closed container with a child-resistant closure. It is important to keep this medication out of the reach of children. The tablets are manufactured and distributed by Advagen Pharma Limited and Rubicon Research Private Limited, respectively. The manufacturing license number is KD-682.*

Each tablet contains glipiZIDE 10 mg. It should be stored at a temperature between 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The tablets should be dispensed in a tightly closed container with a child-resistant closure. This medication should be kept out of the reach of children. The tablets are distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India.*

This text provides information about a medication called glipiZIDE, specifically glipiZIDE tablets containing 2.5 mg of glipiZIDE. The recommended storage temperature for the tablets is between 20°C to 25°C (68°F to 77°F) with permitted excursions between 15°C to 30°C (59°F to 86°F). The tablets should be dispensed in a tightly closed container with a child-resistant closure. The medication is intended for prescription use only. The text also provides the National Drug Code (NDC) for the product as 72888-115-30. Additionally, it mentions the name and address of the distributor and the manufacturer. The manufacturing license number is listed as KD-682 XX.*

Each tablet contains 2.5 mg of the active ingredient glipiZIDE. This medication is intended for use as prescribed, and dosage information can be found in the accompanying prescribing information. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with short-term excursions allowed to a temperature range of 15°C to 30°C (59°F to 86°F). It should be dispensed in a tightly closed container with a child-resistant closure. This medication should be kept out of the reach of children. The product is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India.*

Each tablet contains glipizide, USP 5 mg. Please refer to the accompanying prescribing information for dosage and use. Store the tablets at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). Dispense in a tightly closed container with a child-resistant closure. Keep this medication out of the reach of children. The product is distributed by Advagen Pharma Limited in Plainsboro, NJ, USA and manufactured by Rubicon Research Private Limited in Ambernath, India. The manufacturing license number is KD-682.*

Each tablet contains 5 mg of glipizide, a medication used to treat diabetes. It is recommended to refer to the accompanying prescribing information for dosage and use instructions. The tablets should be stored at a temperature of 20-25°C (68-77°F) with permitted excursions to 15-30°C (59-86°F), following USP Controlled Room Temperature guidelines. They should be dispensed in a tightly closed container with a child-resistant closure. It is important to keep this medication out of the reach of children. The tablets are distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India.*

This is a description of a medication called glipizide. Each tablet contains 5 mg of glipizide. The recommended dosage and use information can be found in the accompanying prescribing information. The tablets should be stored at a temperature between 20 to 25°C (68 to 77°F), with allowed excursions to 15 to 30°C (59 to 86°F). They should be dispensed in a tightly closed container with a child-resistant closure. It is important to keep this medication and all other medications out of the reach of children. The NDC number for this product is 72888-116-05. The tablets are distributed by Advagen Pharma Limited, located at 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA. They are manufactured by Rubicon Research Private Limited in Ambernath, Dist. Thane, 421506 India. The manufacturing license number is KD-682.*